دورية أكاديمية
أعرض في EDS

Biochemical, Hematological, Inflammatory, and Gut Permeability Biomarkers in Patients with Alcohol Withdrawal Syndrome with and without Delirium Tremens.

التفاصيل البيبلوغرافية
العنوان: Biochemical, Hematological, Inflammatory, and Gut Permeability Biomarkers in Patients with Alcohol Withdrawal Syndrome with and without Delirium Tremens.
المؤلفون: Melamud MM; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia., Bobrik DV; Department of Psychiatry and Addiction, Bashkir State Medical University, 450008 Ufa, Russia., Brit PI; Department of Natural Sciences, Novosibirsk State University, 630090 Novosibirsk, Russia., Efremov IS; Institute of Personalized Psychiatry and Neurology, Shared Core Facilities, V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology, 192019 Saint Petersburg, Russia., Buneva VN; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.; Department of Natural Sciences, Novosibirsk State University, 630090 Novosibirsk, Russia., Nevinsky GA; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.; Department of Natural Sciences, Novosibirsk State University, 630090 Novosibirsk, Russia., Akhmetova EA; Department of Psychiatry and Addiction, Bashkir State Medical University, 450008 Ufa, Russia.; Institute of Personalized Psychiatry and Neurology, Shared Core Facilities, V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology, 192019 Saint Petersburg, Russia., Asadullin AR; Department of Psychiatry and Addiction, Bashkir State Medical University, 450008 Ufa, Russia.; Institute of Personalized Psychiatry and Neurology, Shared Core Facilities, V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology, 192019 Saint Petersburg, Russia., Ermakov EA; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.; Department of Natural Sciences, Novosibirsk State University, 630090 Novosibirsk, Russia.
المصدر: Journal of clinical medicine [J Clin Med] 2024 May 08; Vol. 13 (10). Date of Electronic Publication: 2024 May 08.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG, [2012]-
مستخلص: Background: Delirium Tremens (DT) is known to be a serious complication of alcohol withdrawal syndrome (AWS). Neurotransmitter abnormalities, inflammation, and increased permeability are associated with the pathogenesis of AWS and DT. However, the biomarkers of these conditions are still poorly understood. Methods: In this work, biochemical, hematologic, inflammatory, and gut permeability biomarkers were investigated in the following three groups: healthy controls (n = 75), severe AWS patients with DT (n = 28), and mild/moderate AWS without DT (n = 97). Blood sampling was performed after resolution of the acute condition (on 5 ± 1 day after admission) to collect clinical information from patients and to investigate associations with clinical scales. Biomarker analysis was performed using automated analyzers and ELISA. Inflammatory biomarkers included the erythrocyte sedimentation rate (ESR), high-sensitivity C-reactive protein (hsCRP), and platelet-to-lymphocyte ratio (PLR). Results: Among the biochemical biomarkers, only glucose, total cholesterol, and alanine aminotransferase (ALT) changed significantly in the analyzed groups. A multiple regression analysis showed that age and ALT were independent predictors of the CIWA-Ar score. Hematologic biomarker analysis showed an increased white blood cell count, and the elevated size and greater size variability of red blood cells and platelets (MCV, RDWc, and PDWc) in two groups of patients. Gut permeability biomarkers (FABP2, LBP, and zonulin) did not change, but were associated with comorbid pathologies (alcohol liver disease and pancreatitis). The increase in inflammatory biomarkers (ESR and PLR) was more evident in AWS patients with DT. Cluster analysis confirmed the existence of a subgroup of patients with evidence of high inflammation, and such a subgroup was more frequent in DT patients. Conclusions: These findings contribute to the understanding of biomarker variability in AWS patients with and without DT and support the heterogeneity of patients by the level of inflammation.
References: Cells. 2020 Aug 17;9(8):. (PMID: 32824536)
Clin Hypertens. 2016 Jan 04;22:1. (PMID: 26893936)
Addict Biol. 2021 Jan;26(1):e12838. (PMID: 31713961)
Eurasian J Med. 2023 Feb;55(1):78-82. (PMID: 36861872)
Addiction. 2022 Mar;117(3):804-814. (PMID: 34288186)
Alcohol Res. 2017;38(2):163-171. (PMID: 28988571)
Brain Behav Immun. 2022 Nov;106:67-75. (PMID: 35953022)
Przegl Lek. 2014;71(9):469-74. (PMID: 25632784)
Front Immunol. 2022 Sep 27;13:975027. (PMID: 36238273)
PLoS Med. 2020 Dec 4;17(12):e1003410. (PMID: 33275596)
Addiction. 1993 Jun;88(6):791-804. (PMID: 8329970)
Addict Biol. 2022 Jul;27(4):e13182. (PMID: 35754106)
World J Biol Psychiatry. 2019 Jan;20(1):76-90. (PMID: 28669319)
Addict Biol. 2021 Mar;26(2):e12907. (PMID: 32307834)
Front Psychiatry. 2023 Sep 22;14:1266424. (PMID: 37810604)
Arterioscler Thromb Vasc Biol. 1998 Apr;18(4):650-4. (PMID: 9555872)
Alcohol Clin Exp Res. 2014 Oct;38(10):2664-77. (PMID: 25346507)
Diabetes Metab J. 2012 Apr;36(2):108-15. (PMID: 22540046)
Eur J Trauma Emerg Surg. 2022 Jun;48(3):1569-1577. (PMID: 33839799)
Drugs. 2022 Feb;82(3):251-274. (PMID: 35133639)
Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):E4485-93. (PMID: 25288760)
Nat Sci Sleep. 2021 Aug 12;13:1419-1428. (PMID: 34413689)
Biomed Res Int. 2021 Feb 15;2021:8867985. (PMID: 33644233)
N Engl J Med. 2014 Nov 27;371(22):2109-13. (PMID: 25427113)
Front Psychiatry. 2022 Aug 11;13:931280. (PMID: 36032219)
Alcohol Clin Exp Res. 1999 Mar;23(3):471-5. (PMID: 10195820)
Alcohol Clin Exp Res. 2020 Dec;44(12):2555-2560. (PMID: 33067833)
Alcohol Clin Exp Res. 2018 Jan;42(1):32-40. (PMID: 29030980)
Alcohol. 2020 Aug;86:93-101. (PMID: 32335269)
Alcohol Clin Exp Res. 1999 Feb;23(2):204-8. (PMID: 10069546)
Br J Psychiatry. 1979 Apr;134:382-9. (PMID: 444788)
Transl Psychiatry. 2017 Feb 28;7(2):e1048. (PMID: 28244981)
Braz J Psychiatry. 2022 Aug 22;44(5):548-556. (PMID: 35995431)
Transl Gastroenterol Hepatol. 2020 Apr 05;5:19. (PMID: 32258523)
J Clin Med Res. 2013 Oct;5(5):376-80. (PMID: 23976910)
Lancet. 2001 Mar 10;357(9258):763-7. (PMID: 11253971)
Alcohol Clin Exp Res. 1992 Oct;16(5):895-8. (PMID: 1332524)
J Clin Endocrinol Metab. 1997 May;82(5):1313-6. (PMID: 9141509)
Alcohol. 2023 Jun;109:43-48. (PMID: 36709009)
Psychiatry (Edgmont). 2007 Jul;4(7):28-37. (PMID: 20526405)
Alcohol Alcohol. 2019 Jan 9;54(5):503-509. (PMID: 31403690)
Sci Rep. 2017 Jun 30;7(1):4462. (PMID: 28667254)
Lancet. 2022 Jul 16;400(10347):185-235. (PMID: 35843246)
Alcohol. 2020 Aug;86:9-16. (PMID: 32330589)
J Immunoassay Immunochem. 2024 Jan 2;45(1):38-49. (PMID: 37953614)
J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):854-62. (PMID: 17986499)
Neuropsychopharmacology. 2024 Jan;49(1):317-318. (PMID: 37550437)
JAMA. 2013 Nov 27;310(20):2191-4. (PMID: 24141714)
Alcohol Alcohol. 2024 Jan 17;59(2):. (PMID: 38469882)
Br J Addict. 1989 Nov;84(11):1353-7. (PMID: 2597811)
Nat Clin Pract Gastroenterol Hepatol. 2007 Sep;4(9):521-6. (PMID: 17768397)
J Pers Soc Psychol. 1992 Sep;63(3):452-9. (PMID: 1403624)
J Lab Clin Med. 2001 Nov;138(5):332-7. (PMID: 11709657)
Can J Cardiol. 2020 May;36(5):635-647. (PMID: 32389337)
Eur J Trauma Emerg Surg. 2022 Aug;48(4):2689-2699. (PMID: 33783566)
Brain Sci. 2023 May 22;13(5):. (PMID: 37239308)
Nutrients. 2021 May 14;13(5):. (PMID: 34068838)
Addict Behav. 2020 Mar;102:106128. (PMID: 31865172)
J Intern Med. 2003 Mar;253(3):367-74. (PMID: 12603505)
Alcohol. 2021 Aug;94:43-56. (PMID: 33887366)
Sleep Med. 2001 Jul;2(4):297-307. (PMID: 11438246)
Brain Behav Immun. 2020 Oct;89:501-512. (PMID: 32805393)
Sleep. 1991 Dec;14(6):540-5. (PMID: 1798888)
Gastroenterol Clin Biol. 2008 Aug-Sep;32(8-9):792-7. (PMID: 18757147)
J Immunoassay Immunochem. 2020;41(2):184-194. (PMID: 31842683)
Acta Neurol Scand. 2017 Jan;135(1):4-16. (PMID: 27586815)
Clin Chim Acta. 2006 Jul 23;369(2):148-52. (PMID: 16781697)
Alcohol Alcohol. 2004 Jul-Aug;39(4):336-9. (PMID: 15208167)
Biomed Khim. 2019 Aug;65(5):380-384. (PMID: 31666409)
Am J Physiol Gastrointest Liver Physiol. 2020 Nov 1;319(5):G589-G608. (PMID: 32902315)
Front Psychiatry. 2022 Jan 12;12:797123. (PMID: 35095609)
J Addict. 2015;2015:541536. (PMID: 25810945)
Ann Lab Med. 2019 Jul;39(4):345-357. (PMID: 30809980)
Alcohol. 2014 Nov;48(7):671-6. (PMID: 25262503)
Hepatology. 2003 Aug;38(2):518-26. (PMID: 12883497)
Scand J Clin Lab Invest. 2020 Oct;80(6):500-507. (PMID: 32673141)
معلومات مُعتمدة: 23-75-01136 Russian Science Foundation
فهرسة مساهمة: Keywords: Delirium Tremens; FABP2; LBP; alcohol use disorder; alcohol withdrawal syndrome; biochemical test; blood test; gut permeability; inflammation; zonulin
تواريخ الأحداث: Date Created: 20240525 Latest Revision: 20240527
رمز التحديث: 20240527
مُعرف محوري في PubMed: PMC11121978
DOI: 10.3390/jcm13102776
PMID: 38792318
قاعدة البيانات: MEDLINE
الوصف
تدمد:2077-0383
DOI:10.3390/jcm13102776